Press release
Lawsuit filed for Investors who lost money with shares of Viatris Inc. (NASDAQ: VTRS)
A lawsuit was filed on behalf of investors in Viatris Inc. (NASDAQ: VTRS) shares over alleged securities laws violations.
Investors who purchased shares of Viatris Inc. (NASDAQ: VTRS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 03, 2025. NASDAQ: VTRS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Canonsburg, PA based Viatris Inc. operates as a healthcare company worldwide.
On February 27, 2025, Viatris Inc. announced its financial results for the fourth quarter and full fiscal year 2024 and provided disappointing fiscal 2025 guidance. The Company attributed below-expectation guidance on "the expected financial impact from Indore facility warning letter and import alert." Following this news, the price of Viatris' common stock declined dramatically.
Shares of Viatris Inc. (NASDAQ: VTRS) declined from $13.55 per share on November 25, 2024 to as loiw as $8.77 per share on February 27, 2025.
According to the complaint the plaintiff alleges on behalf of purchasers of Viatris Inc. (NASDAQ: VTRS) common shares between August 8, 2024 and February 26, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 8, 2024 and February 26, 2025, the
Those who purchased shares of Viatris Inc. (NASDAQ: VTRS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Viatris Inc. (NASDAQ: VTRS) here
News-ID: 3972384 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc.
Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation…
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc.
Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: RXST…
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc.
Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Viatris
Abacavir Market is Booming Worldwide with GlaxoSmithKline, Viatris, Cipla
The latest study released on the Global Abacavir Market by HTF MI evaluates market size, trend, and forecast to 2031. The Abacavir market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This Report…
Pediatric Healthcare Industry May See a Big Move |Boehringer Ingelheim, Glaxosmi …
Data Insights Market published a new research publication on "Pediatric Healthcare Industry Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Pediatric Healthcare Industry was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Naloxone Market Growth in Future Scope 2024-2031 | Akorn, Inc, Hikma Pharmaceuti …
The Latest research report on the Naloxone Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Naloxone Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics, cost structures,…
Influenza Vaccines Industry May See a Big Move | BIKEN, Viatris, Sinovac Biotech
Data Insights Market published a new research publication on "Influenza Vaccines Industry Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Influenza Vaccines Industry was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Motion Sickness Drugs Market Is Booming Worldwide | Hylands,Perrigo, Viatris
The "Motion Sickness Drugs Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Motion Sickness Drugs Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major…
Pulmonary Arterial Hypertension Market Is Booming Worldwide with Bayer, Sandoz, …
Pulmonary Arterial Hypertension Market latest research report added by USD Analytics. The Pulmonary Arterial Hypertension Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in…
